View Latest Medical and Pharma Bids and Tenders

Advanced Search

Pharmaceuticals Drug Formulation Tenders and Contracts

Pharmaceuticals Drug Formulation tenders contracts bids and business opportunities -

Summary:
Results Announcement Of Guangdong Pharmaceutical University New Drug R&D Center (Formulation Platform) Equipment Procurement Project [Gdjy241009001Hg060]
Country:
China
Estimated Cost:
CNY 372000000
Notice Type:
Contract Award
Deadline:
Posting Date:
06 Dec 2024
 
 
 
Summary:
Chongqing University Drug Analysis Platform And New Formulation Platform Procurement Bid Winning Announcement
Country:
China
 
Notice Type:
Contract Award
Deadline:
Posting Date:
15 Nov 2024
 
 
 
Summary:
Dynamic Purchasing System For Services Related To The Testing Of Clinical Drug Candidates For Palacký University In Olomouc 2024-2027
Country:
Czech Republic
Estimated Cost:
CZK 25000000
Notice Type:
Contract Award
Deadline:
Posting Date:
05 Nov 2024
 
 
 
Summary:
Supply Of The Drug Risperidone (Doe) Parenteral In Monthly Administration Formulation For All Osakidetza Service Organizations And Related Centers
Country:
Spain
 
Notice Type:
Contract Award
Deadline:
Posting Date:
15 May 2023
 
 
 
Summary:
Successive Delivery Of Drugs For The Treatment Of Hepatitis C As Part Of The Drug Program Financed By The National Health Fund For The Needs Of The Wrocławskie Centrum Zdrowia Spzoz
Country:
Poland
 
Notice Type:
Contract Award
Deadline:
Posting Date:
07 Apr 2023
 
 
 
Summary:
Laboratory Campus In The Genome Valley, Hyderabad
Country:
Luxembourg
Estimated Cost:
USD 122916500
Notice Type:
Project
Deadline:
31 Dec 2025
Posting Date:
 
 
 
Summary:
Biovectra Mrna Vaccine And Biomanufacturing Centre, Charlottetown, Canada
Country:
United States
 
Notice Type:
Project
Deadline:
31 Dec 2023
Posting Date:
 
 
 
Summary:
Wuxi Sta’s Pharmaceutical Manufacturing Campus, Delaware, Usa
Country:
United States
Estimated Cost:
USD 510000000
Notice Type:
Project
Deadline:
31 Dec 2025
Posting Date:
 
 
 
Summary:
This Institution Assumes Strategic Planning As A Tool Of The National Planning And Public Investment System, With The Purpose Of Aligning National And International Commitments In A Unique And Coherent Framework That Allows Progress In The Achievement Of The Different Objectives And Ensures The Reduction Of Demand And Control Of Drug Supply By Obtaining The Institutional Results That Respond To The Results Of Government And In Turn, To The Policies Of The State. Given The Dynamic And Complex Nature Of The Drug Phenomenon That Has Once Again Become Evident In The Context Of The Covid-19 Pandemic; The Institutional Strategy 2021-2024 Adopts A Future-Oriented Approach To Change To Guarantee A Safe Response To The New Challenges. In That Sense, The Institutional Strategic Plan Includes Four (4) Specific Guidelines, Detailed Below: • Institutional Strengthening: Try To Apply A Model Of Comprehensive And Quality Management To Guarantee The Efficiency In The Development Of Drug Policies And Thus Overcome The Weaknesses Of Inter -Institutional Coordination Of Territorial And Sectoral Groups Taking Advantage Of The Conditions And Provisions Of All Actors Of Society. • Demand Reduction: Seeks To Avoid And Prevent Drug Use, As Well As Address The Negative Consequences For Both Health And Society Originated By The Improper Use Of Drugs, Through The Formulation, Articulation, Implementation And Monitoring Of Public Drug Policies In The Educational, Community, Labor, Sports And Policies Of Treatment, Rehabilitation And Social Reintegration. • Research: Refers To The Availability Of Updated And Reliable Information To Provide Users With Useful Information With Quality And Veracity, Both For Citizens In General And For Public And Private Institutions, Educational And Research Centers. • International Relations: Strengthening And Improving The Relationship With International Cooperation Mechanisms Of Which The Country Is Signatory, With The Purpose Of Promoting Good Drug Pract
Country:
Dominican Republic
Estimated Cost:
DOP 63373827
Notice Type:
Procurement Plan
Deadline:
20 Mar 2026
Posting Date:
21 Mar 2025
 
 
 
Summary:
European Regimen Accelerator For Tuberculosis
Country:
Spain
Estimated Cost:
USD 241381609
Notice Type:
Project
Deadline:
31 Dec 2025
Posting Date: